Ron Cohen

2014

In 2014, Ron Cohen earned a total compensation of $4M as President and Chief Executive Officer at Acorda Therapeutics, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$651,600
Option Awards$1,939,685
Salary$745,833
Stock Awards$700,413
Other$7,650
Total$4,045,181

Cohen received $1.9M in option awards, accounting for 48% of the total pay in 2014.

Cohen also received $651.6K in non-equity incentive plan, $745.8K in salary, $700.4K in stock awards and $7.7K in other compensation.

Rankings

In 2014, Ron Cohen's compensation ranked 2,097th out of 13,032 executives tracked by ExecPay. In other words, Cohen earned more than 83.9% of executives.

ClassificationRankingPercentile
All
2,097
out of 13,032
84th
Division
Manufacturing
744
out of 4,966
85th
Major group
Chemicals And Allied Products
236
out of 1,686
86th
Industry group
Drugs
183
out of 1,365
87th
Industry
Biological Products, Except Diagnostic Substances
28
out of 236
88th
Source: SEC filing on April 21, 2017.

Cohen's colleagues

We found six more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2014.

2014

Andrew Hindman

Acorda Therapeutics

Chief Business Development Officer

2014

Jane Wasman

Acorda Therapeutics

General Counsel

2014

Enrique Carrazana

Acorda Therapeutics

Chief Medical Officer

2014

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2014

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

2014

Michael Rogers

Acorda Therapeutics

Chief Financial Officer

News

You may also like